BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 9, 2006
View Archived Issues
Millennium profiles recent highlights
Read More
Antiangiogenic effects of CTCE-9908 could explain its antimetastatic properties
Read More
Gilead Sciences: Q4 review
Read More
Update on H5N1 vaccine development projects
Read More
IND cleared for phase I study of Tramadol ER
Read More
BioSante awarded subcontract for recombinant Factor IX formulation work
Read More
New sugar-cholestanol with anticancer activity
Read More
Phase I/II study shows efficacy of cell therapy for nasopharyngeal carcinoma
Read More
Heparan sulfate mimetics tested against dengue virus and flaviviral encephalitis
Read More
Therapeutic potential of anthrax lethal toxin in Kaposi's sarcoma
Read More
Ono profiles progress of recent months
Read More
APEX-AMI pexelizumab trial set to conclude
Read More
TRO-19622 completes phase I trials
Read More
Solbec prepares for phase II trials of Coramsine
Read More
Akzo Nobel to create two independent companies
Read More
PBT-2 completes phase I program
Read More
European Commission approval for Novartis' acquisition of Chiron
Read More
Fortovase discontinued, Invirase preferred option
Read More
MC4 antagonist/serotonin transport inhibitor for stress-related anxiety and depression
Read More
New Abilify options now available
Read More
New treatments for hepatitis C described in recent Boehringer Ingelheim patent
Read More
Novel agents imparted for inflammatory disorders
Read More
Potent targeting of c-Fos enhances the antiosteogenic activity of new vitamin D analogues
Read More